These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mixed (neutrophil-rich) interstitial pneumonitis in biopsy specimens of lung allografts: a clinicopathologic evaluation. McDonald JW; Keller CA; Ramos RR; Brunt EM Chest; 1998 Jan; 113(1):117-23. PubMed ID: 9440578 [TBL] [Abstract][Full Text] [Related]
3. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome. Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342 [TBL] [Abstract][Full Text] [Related]
4. Bronchiolitis obliterans organizing pneumonia-like reactions: a nonspecific response or an atypical form of rejection or infection in lung allograft recipients? Siddiqui MT; Garrity ER; Husain AN Hum Pathol; 1996 Jul; 27(7):714-9. PubMed ID: 8698317 [TBL] [Abstract][Full Text] [Related]
5. Single-institution study evaluating the utility of surveillance bronchoscopy after lung transplantation. Valentine VG; Gupta MR; Weill D; Lombard GA; LaPlace SG; Seoane L; Taylor DE; Dhillon GS J Heart Lung Transplant; 2009 Jan; 28(1):14-20. PubMed ID: 19134525 [TBL] [Abstract][Full Text] [Related]
6. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803 [TBL] [Abstract][Full Text] [Related]
7. Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation. Sato M; Hwang DM; Ohmori-Matsuda K; Chaparro C; Waddell TK; Singer LG; Hutcheon MA; Keshavjee S J Heart Lung Transplant; 2012 Apr; 31(4):354-63. PubMed ID: 22330935 [TBL] [Abstract][Full Text] [Related]
8. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation. Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723 [TBL] [Abstract][Full Text] [Related]
9. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients? Hadjiliadis D; Davis RD; Palmer SM Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838 [TBL] [Abstract][Full Text] [Related]
10. Use of C4d as a diagnostic adjunct in lung allograft biopsies. Magro CM; Pope Harman A; Klinger D; Orosz C; Adams P; Waldman J; Knight D; Kelsey M; Ross P Am J Transplant; 2003 Sep; 3(9):1143-54. PubMed ID: 12919095 [TBL] [Abstract][Full Text] [Related]
11. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome? Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382 [TBL] [Abstract][Full Text] [Related]
12. Interstitial inflammatory lesions of the pulmonary allograft: a retrospective analysis of 2697 transbronchial biopsies. Burton CM; Iversen M; Carlsen J; Andersen CB Transplantation; 2008 Sep; 86(6):811-9. PubMed ID: 18813106 [TBL] [Abstract][Full Text] [Related]
13. Prospective study of the value of transbronchial lung biopsy after lung transplantation. Boehler A; Vogt P; Zollinger A; Weder W; Speich R Eur Respir J; 1996 Apr; 9(4):658-62. PubMed ID: 8726927 [TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation. Luckraz H; Sharples L; McNeil K; Wreghitt T; Wallwork J J Heart Lung Transplant; 2003 Mar; 22(3):287-91. PubMed ID: 12633696 [TBL] [Abstract][Full Text] [Related]
16. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Weigt SS; Elashoff RM; Huang C; Ardehali A; Gregson AL; Kubak B; Fishbein MC; Saggar R; Keane MP; Saggar R; Lynch JP; Zisman DA; Ross DJ; Belperio JA Am J Transplant; 2009 Aug; 9(8):1903-11. PubMed ID: 19459819 [TBL] [Abstract][Full Text] [Related]
17. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787 [TBL] [Abstract][Full Text] [Related]
18. Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis. Manuel O; Kumar D; Moussa G; Chen MH; Pilewski J; McCurry KR; Studer SM; Crespo M; Husain S; Humar A Transplantation; 2009 Mar; 87(5):719-25. PubMed ID: 19295317 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience. Rao U; Sharma M; Mohanakumar T; Ahn C; Gao A; Kaza V Transpl Immunol; 2019 Jun; 54():65-72. PubMed ID: 30794945 [TBL] [Abstract][Full Text] [Related]
20. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1. Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]